These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
476 related articles for article (PubMed ID: 17083811)
1. [Construction and utilization of the prognostic model of serous ovarian adenocarcinoma]. Yang R; Feng J; Fang XZ; Bai F; Cheng YX; Liu C; Zhu W; Li L Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):459-63. PubMed ID: 17083811 [TBL] [Abstract][Full Text] [Related]
2. [Classification tree analysis in serous ovarian adenocarcinoma patients for prognostic factors associated with three-year survival probability]. Zhu HL; Li Y; Zhao YM; Cui H; Zhao Y; Chang XH; Feng J; Wei LH Zhonghua Fu Chan Ke Za Zhi; 2008 Mar; 43(3):201-4. PubMed ID: 18788570 [TBL] [Abstract][Full Text] [Related]
3. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence]. Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194 [TBL] [Abstract][Full Text] [Related]
4. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study. Chan JK; Tian C; Monk BJ; Herzog T; Kapp DS; Bell J; Young RC; Cancer; 2008 May; 112(10):2202-10. PubMed ID: 18348296 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of p53 expression in advanced-stage ovarian serous borderline tumors. Gershenson DM; Deavers M; Diaz S; Tortolero-Luna G; Miller BE; Bast RC; Mills GB; Silva EG Clin Cancer Res; 1999 Dec; 5(12):4053-8. PubMed ID: 10632339 [TBL] [Abstract][Full Text] [Related]
6. VEGF-A and i-NOS expression are prognostic factors in serous epithelial ovarian carcinomas after complete surgical resection. Engels K; du Bois A; Harter P; Fisseler-Eckhoff A; Kommoss F; Stauber R; Kaufmann M; Nekljudova V; Loibl S J Clin Pathol; 2009 May; 62(5):448-54. PubMed ID: 19126566 [TBL] [Abstract][Full Text] [Related]
7. [Treatment and prognostic factors for stage IV epithelial ovarian cancer]. Wu M; Shen K; Lang J Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):200-3. PubMed ID: 11776158 [TBL] [Abstract][Full Text] [Related]
8. Tissue and serum metalloproteinase (MMP-2) expression in advanced ovarian serous cystoadenocarcinomas: clinical and prognostic implications. Garzetti GG; Ciavattini A; Lucarini G; Goteri G; de e Nictolis M; Garbisa S; Masiero L; Romanini C; Graziella B Anticancer Res; 1995; 15(6B):2799-804. PubMed ID: 8669868 [TBL] [Abstract][Full Text] [Related]
9. [Assessment of prognostic factors in common ovarian tumors of varying malignancy]. Demeter A; Várkonyi T; Csapó Z; Szánthó A; Oláh J; Papp Z Magy Onkol; 2004; 48(3):259-65. PubMed ID: 15520877 [TBL] [Abstract][Full Text] [Related]
10. Does systematic lymphadenectomy have a benefit on survival of suboptimally debulked patients with stage III ovarian carcinoma? A DEGOG* Study. Saygili U; Guclu S; Uslu T; Erten O; Ture S; Demir N J Surg Oncol; 2002 Nov; 81(3):132-7. PubMed ID: 12407725 [TBL] [Abstract][Full Text] [Related]
11. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent. Silva EG; Gershenson DM; Malpica A; Deavers M Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075 [TBL] [Abstract][Full Text] [Related]
12. [Recurrence risk factors of platinum-sensitive epithelial ovarian cancer]. Yan XJ; Liang LZ; Zeng ZY; Liu JH; Yuan SH; Wei M Ai Zheng; 2005 Jun; 24(6):751-4. PubMed ID: 15946495 [TBL] [Abstract][Full Text] [Related]
13. p53 overexpression is not an independent prognostic factor for patients with primary ovarian epithelial cancer. Eltabbakh GH; Belinson JL; Kennedy AW; Biscotti CV; Casey G; Tubbs RR; Blumenson LE Cancer; 1997 Sep; 80(5):892-8. PubMed ID: 9307189 [TBL] [Abstract][Full Text] [Related]
14. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study. Winter WE; Maxwell GL; Tian C; Sundborg MJ; Rose GS; Rose PG; Rubin SC; Muggia F; McGuire WP; J Clin Oncol; 2008 Jan; 26(1):83-9. PubMed ID: 18025437 [TBL] [Abstract][Full Text] [Related]
15. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma. Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146 [TBL] [Abstract][Full Text] [Related]
16. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas]. Shao HL; Shen DH; Xue WC; Li Y; Yu YZ Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760 [TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up and prognostic factor analysis in clear cell adenocarcinoma of the ovary. Mizuno M; Kikkawa F; Shibata K; Kajiyama H; Ino K; Kawai M; Nagasaka T; Nomura S J Surg Oncol; 2006 Aug; 94(2):138-43. PubMed ID: 16847906 [TBL] [Abstract][Full Text] [Related]
18. [Effect of retroperitoneal lymphadenectomy on survival of patients with epithelial ovarian cancer]. Xiong ZF; Wang ZH; Wang SX Zhonghua Fu Chan Ke Za Zhi; 2003 Feb; 38(2):77-80. PubMed ID: 12783692 [TBL] [Abstract][Full Text] [Related]
19. [Clinical and pathological features of borderline ovarian tumors]. Li Y; Cui H; Shen DH; Zhao Y; Wei LH; Qian HN Zhonghua Fu Chan Ke Za Zhi; 2003 Feb; 38(2):81-4. PubMed ID: 12783693 [TBL] [Abstract][Full Text] [Related]
20. [Analysis of long-term prognostic factors of epithelial ovarian cancer]. Li MD; Li YJ; Huang YW; Huang H Ai Zheng; 2004 Nov; 23(11):1306-10. PubMed ID: 15522179 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]